Id-1 also confers tumour cells resistance to radio- and chemotherapy-induced apoptosis through the activation of PI3K/Akt/NF-κB signalling pathways (Ling et al, 2006; Li et al, 2007). This evidence concerns the gene NFKB1 and neoplasm.